TRIMODAL PREHABILITATION IN GASTROINTESTINAL CANCER

Recruiting N/A Interventional Study
Digestive Neoplasms
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
30 (estimated)
Sponsor
Puerta de Hierro University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Digestive cancers account for a substantial proportion of oncological patients, representing over 20% of cases treated in hospitals, and are generally managed through a multidisciplinary approach that has markedly improved survival outcomes over recent decades. Surgical resection remains the cornerstone of curative treatment, often preceded by neoadjuvant chemotherapy, radiotherapy, or combined mo…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * More than 18 years old * ECOG 0-2 * Being able to complete the mile-time test * Stages I-III * Being able to understand the informed consent * Gastrointestinal cancer diagnosed Exclusion Criteria: * Metastatic cancer
Contacts

Ana Ruiz Casado MD, PhD, Medical oncologist

607890187

arcasado@salud.madrid.org

CONTACT

María Romero Elías MsC, PhD

634439023

mromero@idiphim.org

CONTACT